SGMO - Sangamo Therape Charts, Trade Ideas, Earnings, Ratings

TRENDING : Top 50 SPY (-0.77%) SPX (-0.77%) TVIX (4.67%) ZS (-1.4%) SPLK (0.93%) RKDA (-8.87%) QQQ (-0.78%) PG (-1.12%) PFE (-1.62%) PANW (0.84%) NVS (-0.45%) MSFT (-0.84%) MRK (-0.63%) MCD (-0.15%) JMIA (-4.29%) IWM (-0.66%) GOOGL (-1.41%) GE (-3.35%) FB (-1.27%) ETHUSD (%) EKSO (-2.44%) DIS (-0.12%) CVX (-1.01%) BTCUSD (%) BBY (-0.34%)

Does Sangamo Therapeutics, Inc.'s (N...	08/17/19
Sandy Macrae has been the CEO of Sangamo Therapeutics, Inc. (NASDAQ:SGMO) since 2016. This analysis aims first to...

Edited Transcript of SGMO earnings confe...	08/14/19
Q2 2019 Sangamo Therapeutics Inc Earnings Call

Sangamo Biosciences Inc (SGMO) Q2 2019 E...	08/09/19
SGMO earnings call for the period ending June 30, 2019.

What You'll Want to Know About Sang...	08/08/19
Pipeline progress was the big story in Q2 for this clinical-stage biotech.

Sangamo Therapeutics (SGMO) Reports Q2 L...	08/07/19
Sangamo (SGMO) delivered earnings and revenue surprises of 25.71% and -9.36%, respectively, for the quarter ended June 2019. Do the numbers hold clues...

Sangamo Therapeutics Reports Second Quar...	08/07/19
Conference Call and Webcast Scheduled for 5:00 p.m. Eastern Time

Sangamo Therapeutics Announces Participa...	08/06/19
Sangamo Therapeutics, Inc. (SGMO), a genomic medicine company, announced today that CEO Sandy Macrae will present at the 2019 Wedbush PacGrow Healthca...

BioMarin (BMRN) Shares Down on Q1 Earnin...	08/02/19
BioMarin (BMRN) announces lower-than-expected earnings and revenues for the second quarter of 2019. It keeps its previously provided revenue guidance ...

HOLDERS

% Insider	12.52%	% Institutional	76.43%

Top 10 Institutional Owners

Vanguard	12.52% (+6.4%)	Bank of America	10.43%
Vanguard	12.52% (+6.4%)	Bank of America	10.43%
Vanguard	12.52% (+6.4%)	Bank of America	10.43%
Vanguard	12.52% (+6.4%)	Bank of America	10.43%
Vanguard	12.52% (+6.4%)	Bank of America	10.43%

Previous Close	$11.60	Open	$11.62
Volume	1.17M	Market Cap	1.09B
Yield		Last Dividend

Date	2019-08-07 (AMC)	Est. (EPS/Rev.)	($0.36)/ 13.58M
Actual (EPS/Rev.)	$-0.26/ $17.55 M	EPS (TTM)	0

Total Revenue	$1.3B	Total Liabilities	$2.1B
Cost of Revenue	$2.5B	Total cash flow	$3.2
Total Assets	$29.98B

Service Name	Trader	% Success
Stocks and Options	Dr. Rao	100.00 %	Follow
Big Data Kornacki & Zhou	Zhou Academy	90.00 %	Subscribe
Write put options!	R. belegger	84.00 %	Subscribe

SGMO - Sangamo Therapeutics

$11.51 -0.09[%]

Add to New List:

Day

52 Week

ANALYST RATINGS

0.00 %

Price Target (PT)

EARNINGS

FINANCE

HOLDERS

Top 10 Institutional Owners

TRADERS TRACKING $SGMO

About Us

Product Types

Strategies

Follow Us

Secure Payments